Collegium Pharmaceutical(us:COLL)
29.33
-1.25%
Updated on 2024-12-23
Open:29.69
Close:29.33
High:30.19
Low:28.97
Pre Close:29.70
Volume:212502.00
Amount:6.22M
Turnover:0.66%
Shares:32.25M
MarketCap:945.90M
About Collegium Pharmaceutical Company
Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.
Company Name: Collegium Pharmaceutical
Company Address: 100 Technology Center Drive,Suite 300
Employees: 197
Fiscar Year: 12-31
IPO Date: 2015-05-07
Website: http://www.collegiumpharma.com
CIK: 1267565
View all SEC Filings
About
Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.
Address:100 Technology Center Drive,Suite 300
Website:http://www.collegiumpharma.com
Market Movers